Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Ardent Health Partners in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Ardent Health Partners’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031299
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net income | $58,488 | $58,965 |
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Depreciation and amortization | 42,986 | 36,201 |
| Other non-operating (gains) losses | (1,886) | 217 |
| Amortization of deferred financing costs and debt discounts | 811 | 1,237 |
| Deferred income taxes | (429) | (1,940) |
| Equity-based compensation | 8,929 | 9,263 |
Item 6. [Exhibits](#ia6f10f802308479b8bc8bad2facfb7e9_217) [38](#ia6f10f802308479b8bc8bad2facfb7e9_217)
FAQ
- What is Ardent Health Partners's D&A?
- Ardent Health Partners (ARDT) reported D&A of $42.99M in Q1 2026.
- How has Ardent Health Partners's D&A changed year-over-year?
- Ardent Health Partners's D&A increased by 18.7% year-over-year, from $36.2M to $42.99M.
- What is the long-term trend for Ardent Health Partners's D&A?
- Over 2 years (2022 to 2025), Ardent Health Partners's D&A has grown at a 6.2% compound annual growth rate (CAGR), from $138.17M to $155.7M.
- What does D&A mean?
- Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.
Ask your AI about Ardent Health Partners's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude